Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2016

01-09-2016 | Original Article

Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported

Authors: Timothy R. Card, Sinéad M. Langan, Thomas P. C. Chu

Published in: Digestive Diseases and Sciences | Issue 9/2016

Login to get access

Abstract

Background and Aims

Extra-intestinal manifestations are well recognized in inflammatory bowel disease (IBD). To what extent the commonly recognized extra-intestinal manifestations seen in IBD patients are attributable to IBD is, however, not clear due to the limited number of controlled studies published.

Methods

We have conducted a study of these manifestations using electronic primary care records. We have identified extra-intestinal manifestations in IBD and non-IBD patients and derived odds ratios (ORs) using conditional logistic regression.

Results

A total of 56,097 IBD patients (32.5 % Crohn’s disease, 48.3 % ulcerative colitis (UC) and 19.2 % not classified) were matched to 280,382 non-IBD controls. We found records of pyoderma gangrenosum (OR = 29.24), erythema nodosum (OR = 5.95), primary sclerosing cholangitis (OR = 188.25), uveitis (OR = 2.81), ankylosing spondylitis (OR = 7.07), sacroiliitis (OR = 2.79) and non-rheumatoid inflammatory arthritides (OR = 2.66) to be associated with IBD. One or more of these was recorded in 8.1 % of IBD patients and 2.3 % of controls. Non-specific arthritides were present in many more patients, affecting 30 % of IBD patients and 23.8 % of controls overall. We also found weaker associations with a number of conditions not generally considered to be extra-intestinal manifestations including psoriasis, ischemic heart disease, multiple sclerosis and hay fever.

Conclusion

Although “classical” extra-intestinal manifestations are strongly associated with IBD, most IBD patients remain unaffected. Arthropathies, perceived to be the commonest extra-intestinal manifestation, are not strongly associated with IBD, and the proportion of arthropathies attributable to IBD is likely to be small.
Literature
1.
go back to reference Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.PubMed Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434.PubMed
5.
6.
go back to reference Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–2307. http://www.ncbi.nlm.nih.gov/pubmed/14562397. Accessed Jun 12, 2013. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300–2307. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​14562397. Accessed Jun 12, 2013.
9.
go back to reference Alonso Farto JC, Arias IA, Lopez Longo FJ, et al. Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies. Eur J Nucl Med. 2000;27:1768–1773. doi:10.1007/s002590000393.CrossRef Alonso Farto JC, Arias IA, Lopez Longo FJ, et al. Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies. Eur J Nucl Med. 2000;27:1768–1773. doi:10.​1007/​s002590000393.CrossRef
11.
go back to reference Langan SM, Groves RW, Card TR, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166–2170. doi:10.1038/jid.2012.130.CrossRefPubMed Langan SM, Groves RW, Card TR, et al. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol. 2012;132:2166–2170. doi:10.​1038/​jid.​2012.​130.CrossRefPubMed
12.
go back to reference Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2002;11:211–218. doi:10.1002/pds.698.CrossRefPubMed Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf. 2002;11:211–218. doi:10.​1002/​pds.​698.CrossRefPubMed
14.
go back to reference Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom. Pharmacoepidemiol Drug Saf. 1992;1:347–349. doi:10.1002/pds.2630010607.CrossRef Jick H, Terris BZ, Derby LE, et al. Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom. Pharmacoepidemiol Drug Saf. 1992;1:347–349. doi:10.​1002/​pds.​2630010607.CrossRef
18.
go back to reference Christodoulou DK, Katsanos KH, Kitsanou M, et al. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis. 2002;34:781–786.CrossRefPubMed Christodoulou DK, Katsanos KH, Kitsanou M, et al. Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis. 2002;34:781–786.CrossRefPubMed
21.
go back to reference Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology. 2005;129:819–826.CrossRefPubMed Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology. 2005;129:819–826.CrossRefPubMed
Metadata
Title
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported
Authors
Timothy R. Card
Sinéad M. Langan
Thomas P. C. Chu
Publication date
01-09-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4195-1

Other articles of this Issue 9/2016

Digestive Diseases and Sciences 9/2016 Go to the issue